Newsletter insight
Zambia and China's Jijia Sign US$213 Million Vaccine Plant Deal
Perspectives from the HPC business newsletter.
← All business news
Zambia's Industrial Development Corporation and China's Jijia signed a joint venture agreement to establish a vaccine manufacturing plant, with planned investment of approximately US$213 million. The first phase is expected to establish a cholera-vaccine...
Zambia's Industrial Development Corporation and China's Jijia signed a joint venture agreement to establish a vaccine manufacturing plant, with planned investment of approximately US$213 million. The first phase is expected to establish a cholera-vaccine facility in Lusaka.
The project creates potential demand for pharmaceutical machinery, laboratory equipment, cold-chain systems and specialist engineering. Healthcare suppliers and technical consultants can explore future manufacturing and operational requirements.